← Open Payments lookup

KENDALL ESTES: Open Payments

NPI 1083476436 · REFORM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,083 in 57 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,096 · 2025 $1,083

Food & beverage: $1,083
CompanyPaymentsAmount
ABBVIE INC.13$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$132
Bayer Healthcare Pharmaceuticals Inc.5$108
Otsuka America Pharmaceutical, Inc.5$88
Ardelyx, Inc.4$87
Novo Nordisk Inc4$74
Neurocrine BioSciences, Inc.4$74
Vanda Pharmaceuticals Inc.2$65
Lilly USA, LLC3$55
Axsome Therapeutics, Inc.3$52

Products named: CAPLYTA, Kerendia, REXULTI, IBSRELA, VRAYLAR, INGREZZA, FANAPT, MOUNJARO.

Industry payments across AL — which companies pay providers there.